High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry

Journal of Visualized Experiments

Volumn , Issue 91, 2014, Pages

  Bhattacharya, Subarna ^a   Burridge, Paul W ^b   Kropp, Erin M ^a   Chuppa, Sandra L ^a   Kwok, Wai Meng ^a   Wu, Joseph C ^b   Boheler, Kenneth R ^c,d   Gundry, Rebekah L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocyte; Cellular Biology; Directed differentiation; Flow cytometry; Human induced pluripotent stem cell; IRX4; Issue 91; MCL2v; MLC2a; TNNI3; TNNT2

Indexed keywords

HOMEODOMAIN PROTEIN; IRX4 PROTEIN, HUMAN;

CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; PROCEDURES;

CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

EID: 84908292226     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52010     Document Type: Article

References (65)

1. Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A. 109, E1848-1857, doi:10.1073/pnas.1200250109 1200250109 [pii] (2012).
2. Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc. 8, 162-175, doi:10.1038/nprot.2012.150 nprot.2012.150 [pii] (2013).
3. Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 10, 16-28, doi:S1934-5909(11)00594-7 [pii] 10.1016/j.stem.2011.12.013 (2012).
4. Burridge, P. W. et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 6, e18293, doi:10.1371/journal.pone.0018293 (2011).
5. Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 453, 524-528, doi:nature06894 [pii] 10.1038/nature06894 (2008).
6. Kattman, S. J. et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 8, 228-240, doi:S1934-5909(10)00703-4 [pii] 10.1016/j.stem.2010.12.008 (2011).
7. Willems, E. et al. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res. 109, 360-364, doi:CIRCRESAHA.111.249540 [pii] 10.1161/CIRCRESAHA.111.249540 (2011).
8. Burridge, P. W. et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells. 25, 929-938, doi:2006-0598 [pii] 10.1634/stemcells.2006-0598 (2007).
9. Elliott, D. A. et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods. 8, 1037-1040, doi:10.1038/nmeth.1740 nmeth.1740 [pii] (2011).
10. Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 25, 1015-1024, doi:nbt1327 [pii] 10.1038/nbt1327 (2007).
11. Zhang, Q. et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 21, 579-587, doi:cr2010163 [pii] 10.1038/cr.2010.163 (2011).
12. Uosaki, H. et al. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One. 6, e23657, doi:10.1371/journal.pone.0023657 PONE-D-11-05980 [pii] (2011).
13. Hudson, J., Titmarsh, D., Hidalgo, A., Wolvetang, E., & Cooper-White, J. Primitive Cardiac Cells from Human Embryonic Stem Cells. Stem Cells Dev. 21, 1513-1523, doi:10.1089/scd.2011.0254 (2011).
14. Zhang, J. et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res. 111, 1125-1136, doi:10.1161/CIRCRESAHA.112.273144 CIRCRESAHA.112.273144 [pii] (2012).
15. Ban, K. et al. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA. Circulation. 128, 1897-1909, doi:10.1161/CIRCULATIONAHA.113.004228 CIRCULATIONAHA.113.004228 [pii] (2013).
16. Toyota, N., & Shimada, Y. Differentiation of troponin in cardiac and skeletal muscles in chicken embryos as studied by immunofluorescence microscopy. J Cell Biol. 91, 497-504 (1981).
17. Saggin, L., Gorza, L., Ausoni, S., & Schiaffino, S. Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. Development. 110, 547-554 (1990).
18. Kajioka, S. et al. Endogenous cardiac troponin T modulates Ca(2+)-mediated smooth muscle contraction. Sci Rep. 2, 979, doi:10.1038/srep00979 (2012).
19. Franco, D. et al. Myosin light chain 2a and 2v identifies the embryonic outflow tract myocardium in the developing rodent heart. Anat Rec. 254, 135-146, doi:10.1002/(SICI)1097-0185(19990101)254:1<135::AID-AR17>3.0.CO;2-S [pii] (1999).
20. Franco, D., Lamers, W. H., & Moorman, A. F. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res. 38, 25-53, doi:S0008-6363(97)00321-0 [pii] (1998).
21. Poon, E. et al. Transcriptome-guided functional analyses reveal novel biological properties and regulatory hierarchy of human embryonic stem cell-derived ventricular cardiomyocytes crucial for maturation. PLoS One. 8, e77784, doi:10.1371/journal.pone.0077784 PONE-D-13-28733 [pii] (2013).
22. Lieu, D. K. et al. Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev. 18, 1493-1500, doi:10.1089/scd.2009.0052 (2009).
23. Cao, F. et al. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One. 3, e3474, doi:10.1371/journal.pone.0003474 (2008).
24. Satin, J. et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells. 26, 1961-1972, doi:10.1634/stemcells.2007-0591 2007-0591 [pii] (2008).
25. Itzhaki, I. et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One. 6, e18037, doi:10.1371/journal.pone.0018037 (2011).
26. Bodor, G. S., Porterfield, D., Voss, E. M., Smith, S., & Apple, F. S. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 41, 1710-1715 (1995).
27. Hunkeler, N. M., Kullman, J., & Murphy, A. M. Troponin I isoform expression in human heart. Circ Res. 69, 1409-1414 (1991).
28. Bhavsar, P. K. et al. Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett. 292, 5-8, doi:0014-5793(91)80820-S [pii] (1991).
29. Christoffels, V. M., Keijser, A. G., Houweling, A. C., Clout, D. E., & Moorman, A. F. Patterning the embryonic heart: identification of five mouse Iroquois homeobox genes in the developing heart. Dev Biol. 224, 263-274, doi:10.1006/dbio.2000.9801 S0012-1606(00)99801-4 [pii] (2000).
30. Bruneau, B. G. et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev Biol. 217, 266-277, doi:10.1006/dbio.1999.9548 S0012-1606(99)99548-9 [pii] (2000).
31. Bao, Z. Z., Bruneau, B. G., Seidman, J. G., Seidman, C. E., & Cepko, C. L. Regulation of chamber-specific gene expression in the developing heart by Irx4. Science. 283, 1161-1164 (1999).
32. Nelson, D. O., Jin, D., Downs, K., Kamp, T. J., & Lyons, G. E. Irx4 identifies a chamber-specific cell population that contributes to ventricular myocardium development. Dev Dyn. 243, 381-392, doi:10.1002/dvdy.24078 (2013).
33. Martin, A. F. Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem. 256, 964-968 (1981).
34. Lundy, S. D., Zhu, W. Z., Regnier, M., & Laflamme, M. A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 22, 1991-2002, doi:10.1089/scd.2012.0490 (2013).
35. Farrell, H. M., Jr.et al. Nomenclature of the proteins of cows" milk--sixth revision. Journal of dairy science. 87, 1641-1674, doi:10.3168/jds.S0022-0302(04)73319-6 (2004).
36. Micusan, V. V., & Borduas, A. G. Biological properties of goat immunoglobulins G. Immunology. 32, 373-381 (1977).
37. Lyons, G. E. In situ analysis of the cardiac muscle gene program during embryogenesis. Trends Cardiovasc Med. 4, 70-77, doi:10.1016/1050-1738(94)90012-4 1050-1738(94)90012-4 [pii] (1994).
38. Nakagawa, O., Nakagawa, M., Richardson, J. A., Olson, E. N., & Srivastava, D. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol. 216, 72-84, doi:10.1006/dbio.1999.9454 S0012-1606(99)99454-X [pii] (1999).
39. Xin, M. et al. Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc Natl Acad Sci U S A. 104, 7975-7980, doi:0702447104 [pii] 10.1073/pnas.0702447104 (2007).
40. Davis, L. M., Rodefeld, M. E., Green, K., Beyer, E. C., & Saffitz, J. E. Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol. 6, 813-822 (1995).
41. Minamisawa, S. et al. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem. 278, 9570-9575 (2003).
42. Larsen, T. H. Atrial natriuretic factor in the heart of the human embryo. Acta Anat (Basel). 138, 132-136 (1990).
43. Claycomb, W. C. Atrial-natriuretic-factor mRNA is developmentally regulated in heart ventricles and actively expressed in cultured ventricular cardiac muscle cells of rat and human. Biochem J. 255, 617-620 (1988).
44. Franco, D. et al. Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. Cardiovasc Res. 52, 65-75, doi:S0008636301003492 [pii] (2001).
45. Hoogaars, W. M. et al. The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart. Cardiovasc Res. 62, 489-499, doi:10.1016/j.cardiores.2004.01.030 S0008636304000689 [pii] (2004).
46. Hollenberg, S. M., Sternglanz, R., Cheng, P. F., & Weintraub, H. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol Cell Biol. 15, 3813-3822 (1995).
47. Srivastava, D., Cserjesi, P., & Olson, E. N. A subclass of bHLH proteins required for cardiac morphogenesis. Science. 270, 1995-1999 (1995).
48. Firulli, A. B., McFadden, D. G., Lin, Q., Srivastava, D., & Olson, E. N. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat Genet. 18, 266-270, doi:10.1038/ng0398-266 (1998).
49. Calejo, A. I. et al. Differences in the expression pattern of HCN isoforms among mammalian tissues: sources and implications. Mol Biol Rep. 41, 297-307, doi:10.1007/s11033-013-2862-2 (2013).
50. Stevens, S. M., & Pu, W. T. HCN4 charges up the first heart field. Circ Res. 113, 350-351, doi:10.1161/CIRCRESAHA.113.301981 CIRCRESAHA.113.301981 [pii] (2013).
51. Spater, D. et al. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat Cell Biol. 15, 1098-1106, doi:10.1038/ncb2824 ncb2824 [pii] (2013).
52. Davis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med. 17, 475-484, doi:S1471-4914(11)00078-5 [pii] 10.1016/j.molmed.2011.05.001 (2011).
53. Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 107, 2733-2740, doi:10.1161/01.CIR.0000068356.38592.68 01.CIR.0000068356.38592.68 [pii] (2003).
54. Basu, S., Campbell, H. M., Dittel, B. N., & Ray, A. Purification of specific cell population by fluorescence activated cell sorting (FACS). J Vis Exp. (41), doi:10.3791/1546 1546 [pii] (2010).
55. Dubois, N. C. et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. 29, 1011-1018, doi:10.1038/nbt.2005 nbt.2005 [pii] (2011).
56. Samal, R. et al. OMICS-based exploration of the molecular phenotype of resident cardiac progenitor cells from adult murine heart. J Proteomics. 75, 5304-5315, doi:10.1016/j.jprot.2012.06.010 S1874-3919(12)00435-6 [pii] (2012).
57. Van Hoof, D. et al. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res. 9, 1610-1618, doi:10.1021/pr901138a (2010).
58. Gundry, R. L., Boheler, K. R., Van Eyk, J. E., & Wollscheid, B. A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface. Proteomics Clin Appl. 2, 892-903, doi:10.1002/prca.200780122 (2008).
59. Gundry, R. L., Burridge, P. W., & Boheler, K. R. Pluripotent Stem Cell Heterogeneity and the Evolving Role of Proteomic Technologies in Stem Cell Biology Proteomics. 11, 3947-3961 (2011).
60. Gundry, R. L. et al. A Cell Surfaceome Map for Immunophenotyping and Sorting Pluripotent Stem Cells. Mol Cell Proteomics. 11, 303-316, doi:M112.018135 [pii] 10.1074/mcp.M112.018135 (2012).
61. Bryder, D., Rossi, D. J., & Weissman, I. L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol. 169, 338-346, doi:169/2/338 [pii] (2006).
62. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 21, 759-806 (2003).
63. Shizuru, J. A., Negrin, R. S., & Weissman, I. L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med. 56, 509-538, doi:10.1146/annurev.med.54.101601.152334 (2005).
64. Weissman, I. L., & Shizuru, J. A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 112, 3543-3553 (2008).
65. Boheler, K. R., Bhattacharya S., Chuppa, S., Riordon, D. R., Kropp, E., Burridge, P. W., Wu, J. C., Wersto, R. P., Rao, S., Wollscheid, B., Gundry, R. L. A Human Pluripotent Stem Cell Surface N-Glycoproteome Resource Reveals New Markers, Extracellular Epitopes, and Drug Targets. Stem Cell Reports 3, 185-203 (2014).